These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2918947)

  • 1. Effects of L-carnitine administration on short-chain fatty acid (acetic acid) and long-chain fatty acid metabolism during hemodialysis.
    Maeda K; Shinzato T; Kobayakawa H
    Nephron; 1989; 51(3):355-61. PubMed ID: 2918947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protective role of carnitine in acetate metabolism of patients with uremia treated by hemodialysis].
    Wanic-Kossowska M
    Pol Arch Med Wewn; 1997 Jun; 97(6):534-40. PubMed ID: 9441289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of L-carnitine on arrhythmias during hemodialysis.
    Suzuki Y; Narita M; Yamazaki N
    Jpn Heart J; 1982 May; 23(3):349-59. PubMed ID: 6178854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dialysis on serum carnitine, free fatty acids, and triglyceride levels in man and the rat.
    Bartel LL; Hussey JL; Shrago E
    Metabolism; 1982 Sep; 31(9):944-7. PubMed ID: 7121265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of several factors that intervene in hemodialysis on serum levels of triglycerides and free fatty acids.
    Pérez-García A; Bretó M; Alvarińo J; Alegre B; Cruz JM
    Clin Nephrol; 1979 Jul; 12(1):14-7. PubMed ID: 477051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response patterns to DL-carnitine in patients on maintenance haemodialysis.
    Chan MK; Persaud JW; Varghese Z; Baillod RA; Moorhead JF
    Nephron; 1982; 30(3):240-3. PubMed ID: 7099336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of L-carnitine supplementation on lipid metabolism of renal failure, dialysis-dependent children and adolescents].
    Böhles H; Michalk D; von Wendt-Göknur E
    Infusionstherapie; 1991 Oct; 18(5):224-6. PubMed ID: 1769735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of heparin on the lipid level during hemodialysis].
    Nikolaeva NP; Siniukhin VN; Khokhlov AP; Iarmolinskiĭ IS; Stetsiuk EA
    Urol Nefrol (Mosk); 1990; (5):31-3. PubMed ID: 2264204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dialysate composition on the lipid response to L-carnitine supplementation.
    Zilleruelo G; Novak M; Hsia SL; Goldberg R; Abitbol C; Monkus E; Strauss J
    Kidney Int Suppl; 1989 Nov; 27():S259-63. PubMed ID: 2699997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
    Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of L-carnitine supplementation on lipid parameters in hemodialysis patients.
    Elisaf M; Bairaktari E; Katopodis K; Pappas M; Sferopoulos G; Tzallas C; Tsolas O; Siamopoulos KC
    Am J Nephrol; 1998; 18(5):416-21. PubMed ID: 9730566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting plasma free fatty acids rise during hemodialysis.
    Mingardi G; Branca E; Cini M; Codegoni AM; Mecca G; Bizzi A
    Int J Artif Organs; 1988 Mar; 11(2):95-8. PubMed ID: 3372054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease.
    Evans AM; Faull RJ; Nation RL; Prasad S; Elias T; Reuter SE; Fornasini G
    Kidney Int; 2004 Oct; 66(4):1527-34. PubMed ID: 15458447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis.
    Guarnieri GF; Ranieri F; Toigo G; Vasile A; Ciman M; Rizzoli V; Moracchiello M; Campanacci L
    Am J Clin Nutr; 1980 Jul; 33(7):1489-92. PubMed ID: 7395772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid abnormalities in hemodialysis patients: effect of L-carnitine administration.
    Ahmad S; Dasgupta A; Kenny MA
    Kidney Int Suppl; 1989 Nov; 27():S243-6. PubMed ID: 2636665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of myocardial fatty acid metabolism through L-carnitine administration to chronic hemodialysis patients.
    Sakurabayashi T; Takaesu Y; Haginoshita S; Takeda T; Aoike I; Miyazaki S; Koda Y; Yuasa Y; Sakai S; Suzuki M; Takahashi S; Hirasawa Y; Nakamura T
    Am J Nephrol; 1999; 19(4):480-4. PubMed ID: 10460938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in the plasma values of glucose, free fatty acids, triglycerides and cholesterol in terminal kidney failure during hemodialysis].
    Romanov N; Shipkova P; Kiriakov Z
    Vutr Boles; 1977; 16(4):49-52. PubMed ID: 919513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dialysis-related carnitine disorder and levocarnitine pharmacology.
    Evans A
    Am J Kidney Dis; 2003 Apr; 41(4 Suppl 4):S13-26. PubMed ID: 12751050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary L-carnitine deficiency in chronic hemodialysis patients].
    Achenbach H; Würzberger G; Seim H; Löster H; Strauss B
    Z Gesamte Inn Med; 1989 Jan; 44(1):18-22. PubMed ID: 2711712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-carnitine substitution in patients on chronic hemodialysis.
    Mayer G; Graf H; Legenstein E; Linhart L; Auer B; Lohninger A
    Nephron; 1989; 52(4):295-9. PubMed ID: 2770943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.